Find a Top Internist Near Me in Glendale, AZ – Book an Appointment Instantly

Kiranjit Khalsa, MD, MPH, welcomes patients of all ages at her practice, Premier Allergy Asthma & Immunology, PLLC in Scottsdale, Arizona. With dual board certification in Internal Medicine and Allergy and Immunology, as well as extensive experience in the field, Dr. Khalsa has helped many patients achieve optimal health and wellness. With her diligence and compassion, Dr. Khalsa has also been recognized in Phoenix Magazine's TopDoc.

Dr. Khalsa is a New York native, having received her Bachelor of Science in biology at Stony Brook University in Stony Brook, New York, where she was also selected into a scholarship program for Women in Science and Engineering.

Before entering medical school, she went to State University of New York Downstate Health Sciences University in Brooklyn, New York, where she obtained a Master in Public Health with a specialization in community health science. Her Master's provided her a solid foundation in issues that affect population health, such as disease prevention and promotion of high quality of care

Dr. Khalsa then went on to receive her medical degree from St. George's University. During that time, she was honored to serve as vice president of the Clinical Research Society. She then returned to Stony Brook University to complete an Internal Medicine Residency. From there, she went to Albany Medical College in Albany, New York, for fellowship training in Allergy and Immunology.

In keeping with her ongoing passion for research, Dr. Khalsa has been published as a first author in peer-reviewed academic journals and has co-authored several research studies. She has also presented at national and local allergy and immunology conferences, focusing on topics such as chronic idiopathic urticaria, eosinophilia, and food protein-induced enterocolitis. Throughout her career, Dr. Khalsa has been a strong leader and educator. She plays an active role in medical student and resident education and was recently appointed Clinical Assistant Professor, Department of Pediatrics for Midwestern University and Arizona College of Osteopathic Medicine. 

In addition to her current board certification by the American Board of Internal Medicine and the American Board of Allergy and Immunology, Dr. Khalsa is a member of the American College of Allergy, Asthma, and Immunology. She is also a member of the American Academy of Allergy, Asthma, & Immunology. Her hospital affiliations include Honor Health, where she serves as a member of the board for IPO. 

Dr. Khalsa naturally connects with her patients, taking the time to listen and explain her reasoning. Her demeanor and professionalism have earned her trust among her peers and her patients. In her spare time, Dr. Khalsa enjoys spending time with her family, hiking with her two dogs, and traveling.

Dr. Khalsa is now looking forward to helping you with your allergy needs. She is currently accepting new pediatric and adult patients. To schedule an appointment, call the office or use the online booking feature today.

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Caleb attended Grand Canyon University earning his BSN in 2008 and has practiced at various hospitals in Phoenix, AZ. He attended Wilkes University completing his MSN in psychiatric mental health and is currently a board-certified psychiatric mental health nurse practitioner at 2nd Chance Treatment Center. He has been in the Valley of the Sun for over three decades and considers himself a local. Caleb has a true passion for treating various mental health conditions, believing that every individual can achieve their best vision of who they want to be and perhaps more. He strives to provide excellent care based on current research and methods. Furthermore, he endeavors to treat each individual with dignity and respect. He has practiced as a registered nurse for more than 15 years in various roles before transitioning to mental healthcare.

When he isn’t providing care, he may be encountered outside or indoor rock climbing, pursuing his hobby with dedication. He is involved in the local rock-climbing community, where he has served as a guide and continues to provide instruction for PCGI. Personal recreation is an essential aspect of physical health that Caleb often integrates into treatment, as a healthy body creates a more resilient mind, increasing the capacity for mental healing.

Caleb’s true passion is celebrating and supporting his wife and four children. He shares in their personal hobbies and interests, and they share in his. You may see them on the trails, mountain biking, climbing, or camping.

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Dr. Andrew J. Buresh specializes in medical oncology, hematology, and internal medicine. He is interested in all aspects of clinical oncology and hematology, with a particular interest in gastrointestinal, breast, lung, and prostate cancer, as well as myelodysplasia, coagulation disorders, lymphoma, and myeloma.

Dr. Buresh joined Arizona Center for Cancer Care in 2013 when Desert Springs Cancer Care Center, which he founded and partnered with the practice. He is a member of the American Society of Clinical Oncology, American Society of Hematology and Arizona State Physicians Association.

Dr. Buresh is a multi-year “Top Doc” honoree by Phoenix Magazine and was chosen for the cover of the annual ranking magazine in 2013. He was also honored by the Phoenix Business Journal as among its “40 Top Business Leaders under Age 40.”

Dr. Buresh and his wife are blessed to be the proud parents of three beautiful children. When not caring for patients, Dr. Buresh enjoys spending his time with family, exercising, reading, playing basketball, golf, guitar, and coaching youth sports. He also speaks basic medical Spanish.

Patient Reviews:

"Warm and caring in all aspects of care. He’s special in his approach and looks at the big picture. Spends a lot of time asking questions and is conservative in his approach. So glad I was referred to him and will continue to refer him to others. Don’t be afraid~ take him on your journey with you!" -Robin

"Excellent Hematologist/Oncologist!!!" -Medi

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Teodor Pitea, MD

Teodor Pitea, MD, is a board-certified gastroenterologist and founder of Interventional Endoscopy Associates PLLC in Peoria, Scottsdale, and Phoenix, Arizona.

Dr. Pitea received his medical degree from Iuliu Hațieganu University of Medicine and Pharmacy in Cluj-Napoca, Romania, before moving to the United States in 2001 to pursue a career in gastroenterology. Following a residency in internal medicine, he completed a fellowship in gastroenterology at Mount Sinai Morningside (formerly St. Luke’s-Roosevelt Hospital Center), an affiliate of Columbia University Vagelos College of Physicians and Surgeons. During that time, he also completed a postdoctoral research fellowship on the role of insulin resistance in patients with metabolic syndrome and trained for six months as a hepatology fellow in the Liver Transplant Program at Mount Sinai Hospital. As a gastroenterology fellow, Dr. Pitea discovered his passion for endoscopy, which led him to pursue further training in advanced therapeutic endoscopy under the mentorship of Dr. Stavros Stavropoulos, one of the pioneers of endoscopic surgery, at Winthrop University Hospital in Long Island, New York.

In September 2012, Dr. Pitea launched the Interventional Endoscopy Service at Banner Del E. Webb Medical Center in Sun City West, Arizona. Over the next four years, he spearheaded the building of a new endoscopy unit and developed a highly trained medical team dedicated to interventional endoscopy. Dr. Pitea joined the Digestive Institute at Banner-University Medical Center Phoenix in 2016, and together with Rawad Mounzer, MD, he established the Interventional Endoscopy Service there in collaboration with University of Arizona faculty.

During his role as the Director of Endoscopy and Chief of the Advanced Endoscopy Program, he developed a comprehensive program for the management of acute and chronic pancreatitis, and he has continued to advance the field of endoscopic surgery in Arizona by providing complex, cutting-edge endoscopic interventions.

Dr. Pitea has published multiple abstracts and has been an invited speaker at national conferences. He is a diplomat of the American Board of Internal Medicine as well as the American Board of Gastroenterology.

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/

Dr. Stephanie Lindauer specializes in Medical Oncology, Hematology and Internal Medicine. Her clinical interests include breast cancer and benign breast disease, gastrointestinal cancer and cancer survivorship.

Dr. Lindauer joined Arizona Center for Cancer Care in 2018. She has held a variety of leadership roles. She was Chief Resident of the Department of Internal Medicine, serving an additional year after completing her residency in San Antonio. She also served as Chief Fellow during her last year of fellowship in San Antonio. Dr. Lindauer has several abstracts and poster presentations at local and national meetings, including ASCO Survivorship Symposium, ASCO Quality Care Symposium and ASH Hematologic Malignancies. She is passionate about engagement within her community and has presented at Updates for the San Antonio Community from the San Antonio Breast Cancer Symposium in 2017.

Dr. Lindauer was drawn to the field of oncology from a young age, having seen the effects of cancer in loved ones. She feels honored to be able to fulfill such an important role now and strives for compassion and empathy with all her patients.

Dr. Lindauer is a member of the American Society of Clinical Oncology and American Society of Hematology. She enjoys spending time with her husband and her chocolate lab.

Patient Reviews:

"I have been seeing Dr. Lindauer for over 2 years. She came highly recommended to me by my Lymphedema Therapist. Dr. Lindauer has been very professional, compassionate and patient with me in informing me of my treatment plan for a rare form of cancer." -Vanessa

"I have been seeing Dr. Lindauer for a year now. I'm so glad my breast surgeon Dr. Naomi Sigalove recommended her. She is very compassionate about her patients. She works with all of my other Doctors to insure that I received the best possible care. She never rushed me through a visit and answered all of my questions. Her staff is awesome to. From the front desk to the treatment area. I can't tell you enough how wonderful everyone really is. I will miss everyone in the office when my treatment is over." -Mary

Teodor Pitea, MD

Teodor Pitea, MD, is a board-certified gastroenterologist and founder of Interventional Endoscopy Associates PLLC in Peoria, Scottsdale, and Phoenix, Arizona.

Dr. Pitea received his medical degree from Iuliu Hațieganu University of Medicine and Pharmacy in Cluj-Napoca, Romania, before moving to the United States in 2001 to pursue a career in gastroenterology. Following a residency in internal medicine, he completed a fellowship in gastroenterology at Mount Sinai Morningside (formerly St. Luke’s-Roosevelt Hospital Center), an affiliate of Columbia University Vagelos College of Physicians and Surgeons. During that time, he also completed a postdoctoral research fellowship on the role of insulin resistance in patients with metabolic syndrome and trained for six months as a hepatology fellow in the Liver Transplant Program at Mount Sinai Hospital. As a gastroenterology fellow, Dr. Pitea discovered his passion for endoscopy, which led him to pursue further training in advanced therapeutic endoscopy under the mentorship of Dr. Stavros Stavropoulos, one of the pioneers of endoscopic surgery, at Winthrop University Hospital in Long Island, New York.

In September 2012, Dr. Pitea launched the Interventional Endoscopy Service at Banner Del E. Webb Medical Center in Sun City West, Arizona. Over the next four years, he spearheaded the building of a new endoscopy unit and developed a highly trained medical team dedicated to interventional endoscopy. Dr. Pitea joined the Digestive Institute at Banner-University Medical Center Phoenix in 2016, and together with Rawad Mounzer, MD, he established the Interventional Endoscopy Service there in collaboration with University of Arizona faculty.

During his role as the Director of Endoscopy and Chief of the Advanced Endoscopy Program, he developed a comprehensive program for the management of acute and chronic pancreatitis, and he has continued to advance the field of endoscopic surgery in Arizona by providing complex, cutting-edge endoscopic interventions.

Dr. Pitea has published multiple abstracts and has been an invited speaker at national conferences. He is a diplomat of the American Board of Internal Medicine as well as the American Board of Gastroenterology.

After graduating from a premier medical school in India, Dr. Fernandes continued her training in Internal Medicine and obtained advanced training in the treatment of blood and cancer disorders in the United States. She was awarded an international prestigious scholarship from the European Society of Medical Oncology and spent time as a visiting fellow in Medical Oncology in Spain. 

Her areas of expertise include breast cancers in addition to treating other cancer disorders such as colon cancer, lung cancer, melanoma/skin cancers and blood disorders such as anemias, iron deficiency disorders, abnormal blood counts. She serves as a section editor for Breast Cancer on hemonc.org, an internationally accessed online resource for cancer physicians. She has presented cancer research at national and international cancer meetings in the United States and Europe and volunteers with the American Society of Clinical Oncology for peer review activities.

Dr. Fernandes believes in providing compassionate, exceptional and cutting-edge care to her patients. She strives to provide the most personalized treatment plan for her patients while taking into consideration their unique needs. Having had family members who have also been stricken with cancer, she understands and empathizes with the needs of caring for a loved one with cancer.

Dr. Fernandes enjoys spending time with family, travel, running, and watercolor painting.

Dr. Sanjeev Gopal is a board-certified specialist in medical oncology and hematology with Arizona Center for Cancer Care and Virginia G. Piper Cancer Care Network. 

With offices in Apache Junction, Mesa and Gilbert, Dr. Gopal is committed to providing the highest level of care with a priority of treating each patient and their families with utmost respect. It is important to Dr. Gopal to not only prolong lives of his patients, but to improve the quality of their lives.

Patient Reviews:

"Dr Gopal is fabulous! He is really focused on you and what you are going through! Compassionate and knowledgeable!" -Pat

"Dr. Gopal and his staff are without a doubt the EXCEPTION TO TODAY'S IMPRESSION OF MEDICAL PROVIDERS! Dr. Gopal obviously took the time to hire his staff, because they are just as compassionate, caring, kind and loving as him. Trust me, I am qualified to make these statements; not my first rodeo, ya'll. I don't typically take the time for reviews, but for Dr. Gopal, I absolutely will make an exception as he deserves all the recognition for who he simply is, as a person (I think). Dr. Gopal took a personal interest in my care from the moment I was referred to him. "Bedside manner?" Dr. Gopal treated me like a "person" he cares for, like family. Therefore, that term is not relevant. If you ask me, that is a good thing!...' -Heidi

Dr. Kaplan treats a wide variety of medical oncology, malignant hematology, and benign hematologic disease. She is especially interested in treating breast cancer and general oncology.

Dr. Kaplan enjoys cooking, reading, watching sports, traveling, and spending time with family and her 2 dogs named Penny.

"Dr. Kaplan was a major part of my father-in-love’s cancer treatment and was one of his biggest champions. Her bedside manner was incredibly personalized, kind, and intentional. He couldn’t say enough wonderful things about her. I highly recommend her!" -Leanne

BIOGRAPHY

Dr. Nagaiah received his medical degree from MGR Medical University in India and has been in practice for more than 20 years. His residency and internship were completed at Mercy Catholic Medical Center in Pennsylvania, and he completed a fellowship at West Virginia University. He earned a Masters in Clinical Research from the MGH Institute of Health Professions in Boston. Dr. Nagaiah has expertise in treating lymphoma, lung cancer, and breast cancer, among other conditions.

PHILOSOPHY

I believe that being an oncologist is a privilege that is not to be taken lightly. I strive to provide evidence-based care that is appropriate to my patients’ particular problem, recognizing and respecting individual patient’s wishes. I take a multidisciplinary approach to care, including alternative therapies that have been shown to be effective.

RESEARCH PUBLICATIONS

1. Nagaiah G, Hossain A, Mooney CJ, Parmentier J, Remick SC. Anaplastic thyroid cancer: A review of epidemiology, pathogenesis, and treatment. J Oncol.2011;2011:542358.
   2. Batalo M, Nagaiah G, Abraham J. Cognitive dysfunction in postmenopausal breast cancer patients on aromatase inhibitors. Expert Rev Anticancer Ther.2011;11(8):1277-1282.
   3. Nagaiah G, Remick SC. Combretastatin A4 phosphate: A novel vascular disrupting agent. Future Oncol. 2010;6(8):1219-1228
   4. Mooney CJ, Nagaiah G, Fu P, et al. A phase II trial of fosbretabulin in advanced anaplastic thyroid carcinoma and correlation of baseline serum-soluble intracellular adhesion molecule-1 with outcome. Thyroid. 2009;19(3):233-240.
   5. Nagaiah G, Almubarak M, Khan M, Altaha R. Cerebrospinal fluid leak during treatment with bevacizumab and irinotecan after carmustine-impregnated wafers placement in patients with grade 2 oligodendroglioma and glioblastoma multiforme: Report of two cases and review of literature. Cancer Invest. 2010;28(10):1048-1053

LinkedIn:

https://www.linkedin.com/in/govardhanan-n-ab26a97/